Insights
Humana Inc. Q2 2026 Earnings Analysis
Humana beat Q2 2026 earnings estimates, but cut full-year GAAP EPS guidance again as Star Ratings costs and thinning reserves offset the win.
July 29, 2026
Analysis, playbooks, and research for government-sponsored health plans navigating a faster, more competitive market.
Humana beat Q2 2026 earnings estimates, but cut full-year GAAP EPS guidance again as Star Ratings costs and thinning reserves offset the win.
Centene Q2 2026 earnings beat Wall Street estimates outright, yet shares fell as $0.50 of EPS came from one-time items.
Molina Healthcare Q2 2026 earnings beat estimates as adjusted EPS hit $1.51, even as full-year Marketplace guidance worsened to a $0.75 loss this year.
The most significant finding from UnitedHealth Group’s Q1 2026 results is not the beat itself—it is what the beat signals about the trajectory of the turnaround.
Elevance Q2 2026 earnings beat estimates by 20%, yet shares fell 8.54% as Medicaid concerns dominated the call. Get the full HealthWorks AI breakdown.
Network adequacy is no longer a competitive position in Medicare Advantage. Here is how leading health plans are moving from compliance to sculpting ahead of 2027 bids.
The healthcare payer industry is changing rapidly—and our resources help you stay on top of it all. Sign up to get new insights, success stories, and more, sent right to your inbox.
Thanks for subscribing — keep an eye on your inbox for our next resource.